Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab

NCT02963402 is registered in ClinicalTrials.gov with Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau as lead sponsor.

NCT NCT02963402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02963402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab
Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase
Observational
Overall status
Completed
Start date
November 9, 2016
Completion date
October 1, 2018
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis,rheumatoid